@article{ref1,
title="Serious bromocriptine-induced psychosis: Suicide in the treatment of prolactinoma",
journal="Neurosurgery quarterly",
year="2013",
author="Wang, F. and Zheng, S. and Zhang, Y.",
volume="23",
number="4",
pages="249-251",
abstract="A 35-year-old man, without any prior history or family history of psychosis, developed psychotic symptoms after starting with low-dose bromocriptine therapy for a macroprolactinoma. Seven days after the initiation of treatment with this medication, the patient suddenly plunged to his death in our hospital without any obvious signs. This case suggests a bromocriptine-induced very serious psychosis in which the patient killed himself without a family history and personal history of psychosis. Therefore, as for all patients with bromocriptine, their mood should be cared after, in case they might commit a suicide. We advise caution in the use of bromocriptine even in patients without a preexisting psychiatric history, and we also recommend that such changes in mental status should be monitored when bromocriptine is prescribed. © 2013 by Lippincott Williams and Wilkins.<p /><p>Language: en</p>",
language="en",
issn="1534-4916",
doi="10.1097/WNQ.0b013e318275df80",
url="http://dx.doi.org/10.1097/WNQ.0b013e318275df80"
}